Andrographis Paniculata: A Promising Natural Compound for COVID-19 Drug Discovery

Written By Hiroshi Wald

Herbal Origins: Known in traditional Asian medicine, Andrographis Paniculata (AP) is being explored for COVID-19 treatment.

  • Active Compounds: Features potent compounds, including andrographolide, offering antiviral, anti-inflammatory, and immunomodulatory activities.

  • Research Insights: Recent studies suggest AP's active ingredients inhibit key proteins in SARS-CoV-2, including ACE2 and 3CLpro, crucial for the virus's lifecycle.

  • Clinical Applications: Demonstrates potential in reducing upper respiratory infection symptoms, especially in early treatment stages.

  • Safety Profile: AP is recognized for its safety, with minimal adverse effects in clinical settings.

Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316804/

Keywords: Andrographis paniculata, lead compound, natural product, COVID-19, SARS-CoV-2, antiviral activity, anti-inflammatory activity, immunomodulatory activity

Hiroshi Wald
Previous

Andrographis Paniculata: A Scientific Breakthrough in COVID-19 Management
Next

Thailand approved pilot study on treatment of COVID-19 with Andrographis paniculata